v3.24.1.u1
Condensed Consolidated Statements of Redeemable Non-Controlling Interests and Stockholders' Equity - USD ($)
shares in Thousands, $ in Millions
Total
Redeemable Non-Controlling Interests
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Redeemable non-controlling interests, beginning balance at Dec. 31, 2022 $ 14          
Increase (Decrease) in Temporary Equity [Roll Forward]            
Net loss   $ (1)        
Redeemable non-controlling interests, ending balance at Mar. 31, 2023 13          
Beginning balance (shares) at Dec. 31, 2022     391,471      
Beginning balance at Dec. 31, 2022 6,754   $ 0 $ 10,633 $ (3,846) $ (33)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon settlement of restricted stock units (shares)     3,322      
Issuance of common stock upon exercise of stock options (shares)     1,724      
Issuance of common stock upon exercise of stock options 2     2    
Stock-based compensation 265     265    
Other comprehensive income (loss) 51         51
Repurchase and retirement of common stock (shares)     (6,761)      
Repurchase and retirement of common stock (393)       (393)  
Net loss (161)       (161)  
Ending balance (shares) at Mar. 31, 2023     389,756      
Ending balance at Mar. 31, 2023 6,518   $ 0 10,900 (4,400) 18
Redeemable non-controlling interests, beginning balance at Dec. 31, 2023 7          
Increase (Decrease) in Temporary Equity [Roll Forward]            
Recognition of redeemable non-controlling interest upon additional capital investment 6          
Net loss   $ (2)        
Redeemable non-controlling interests, ending balance at Mar. 31, 2024 11          
Beginning balance (shares) at Dec. 31, 2023     403,228      
Beginning balance at Dec. 31, 2023 $ 6,806   $ 0 11,887 (5,154) 73
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon settlement of restricted stock units (shares)     3,710      
Issuance of common stock upon exercise of stock options (shares) 1,574   1,574      
Issuance of common stock upon exercise of stock options $ 1     1    
Stock-based compensation 289     289    
Other comprehensive income (loss) (74)         (74)
Net loss (23)       (23)  
Ending balance (shares) at Mar. 31, 2024     408,512      
Ending balance at Mar. 31, 2024 $ 6,999   $ 0 $ 12,177 $ (5,177) $ (1)